Compile Data Set for Download or QSAR
Report error Found 50 Enz. Inhib. hit(s) with all data for entry = 50018203
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataEC50: >3.00E+4nMAssay Description:Activation of PXR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Mouse)
Merck

Curated by ChEMBL
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataEC50:  320nMAssay Description:Invivo inhibition of GCS in C57 mouse assessed as reduction in brain GlcCer d18:1/18:0 concentration measured after 8 hrs by LC-MS/MS methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataEC50: >3.00E+4nMAssay Description:Activation of PXR (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406127(CHEMBL5290844 | US20250026762, Compound 7)
Affinity DataIC50: 1nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 1.70nMAssay Description:Inhibition of GCS in human iPSC derived neurons assessed as reduction in brain GlcCer levelsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406126(CHEMBL5291288)
Affinity DataIC50: 6nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406123(CHEMBL5277419)
Affinity DataIC50: 7nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50593123(Venglustat | Genz-682452 | Gz402671 | Ibiglustat |...)
Affinity DataIC50: 12nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Mouse)
Merck

Curated by ChEMBL
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 17nMAssay Description:Inhibition of GCS in mouse fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Mouse)
Merck

Curated by ChEMBL
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataIC50: 21nMAssay Description:Inhibition of GCS in mouse fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406132(CHEMBL5273314 | US20250026762, Compound 30)
Affinity DataIC50: 21nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406137(CHEMBL5286066 | US20250026762, Compound 54)
Affinity DataIC50: 32nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406133(CHEMBL5288633 | US20250026762, Compound 18)
Affinity DataIC50: 32nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 32nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406136(CHEMBL5278676 | US20250026762, Compound 59)
Affinity DataIC50: 32nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406138(CHEMBL5286071 | US20250026762, Compound 61)
Affinity DataIC50: 33nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataIC50: 34nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406131(CHEMBL5278405)
Affinity DataIC50: 35nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406135(CHEMBL5278640 | US20250026762, Compound 55)
Affinity DataIC50: 37nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50593123(Venglustat | Genz-682452 | Gz402671 | Ibiglustat |...)
Affinity DataIC50: 44nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406119(CHEMBL5273405)
Affinity DataIC50: 85nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406128(CHEMBL5270537)
Affinity DataIC50: 180nMAssay Description:Inhibition of GCS in human fibroblastMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataIC50: 224nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406131(CHEMBL5278405)
Affinity DataIC50: 338nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406135(CHEMBL5278640 | US20250026762, Compound 55)
Affinity DataIC50: 585nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406118(CHEMBL5281181)
Affinity DataIC50: 690nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406128(CHEMBL5270537)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406132(CHEMBL5273314 | US20250026762, Compound 30)
Affinity DataIC50: 1.59E+3nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 1.97E+3nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406137(CHEMBL5286066 | US20250026762, Compound 54)
Affinity DataIC50: 2.19E+3nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human alpha3beta4 nAChRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataIC50: 2.20E+3nMAssay Description:Inhibition of human alpha3beta4 nAChRMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406138(CHEMBL5286071 | US20250026762, Compound 61)
Affinity DataIC50: 2.47E+3nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 4.10E+3nMAssay Description:Inhibition of human ERGMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406133(CHEMBL5288633 | US20250026762, Compound 18)
Affinity DataIC50: 4.21E+3nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406122(CHEMBL5286114)
Affinity DataIC50: 7.40E+3nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
Target5-hydroxytryptamine receptor 3A(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406136(CHEMBL5278676 | US20250026762, Compound 59)
Affinity DataIC50: 7.47E+3nMAssay Description:Antagonist activity at human 5HT3A expressed in HEK293 cells incubated for 1 hr by FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetMuscarinic acetylcholine receptor M5(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 1.02E+4nMAssay Description:Inhibition of human muscarinic M5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetMuscarinic acetylcholine receptor M5(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataIC50: 1.02E+4nMAssay Description:Inhibition of human muscarinic M5 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406117(CHEMBL5288301)
Affinity DataIC50: 1.25E+4nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406124(CHEMBL5277877)
Affinity DataIC50: 2.80E+4nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406120(CHEMBL5267915)
Affinity DataIC50: 2.80E+4nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCeramide glucosyltransferase(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406125(CHEMBL5291482)
Affinity DataIC50: 2.80E+4nMAssay Description:Inhibition of Glucosylceramide synthase (unknown origin) using C6-ceramide and UDP-glucose as substrate preincubated for 30 mins followed by substrat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCytochrome P450 2D6(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCytochrome P450 2D6(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP2D6 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCytochrome P450 2C9(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCytochrome P450 2C9(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP2C9 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCytochrome P450 3A4(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406134(CHEMBL5275403)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed
TargetCytochrome P450 3A4(Human)
Merck

Curated by ChEMBL
LigandPNGBDBM50406130(CHEMBL5272946 | US20250026762, Compound 1)
Affinity DataIC50: 5.00E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/18/2024
Entry Details
PubMed